Alpha Paradigm Partners, LLC Jazz Pharmaceuticals PLC Transaction History

Alpha Paradigm Partners, LLC

  • $239 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$141.59 - $168.66 $691,383 - $823,566
4,883 New
4,883 $762 Million
Q4 2021

Feb 14, 2022
SELL
$119.87 - $145.67 $293,441 - $356,600
-2,448 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$128.64 - $184.79 $716,653 - $1.03 Million
-5,571 Reduced 69.47%
2,448 $319 Million
Q2 2021

Aug 13, 2021
BUY
$160.2 - $186.42 $1.28 Million - $1.49 Million
8,019 New
8,019 $1.42 Billion

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email